(Q44332947)

2 December 2017

title

Kinetics of HIV-1 in cerebrospinal fluid and serum after zidovudine treatment (English)

1 reference

2 December 2017

0 references

1 reference

Hagberg L

1

1 reference

2 December 2017

Gisslen M

series ordinal

2

1 reference

2 December 2017

Norkrans G

series ordinal

3

1 reference

2 December 2017

Svennerholm B

series ordinal

4

1 reference

2 December 2017

language of work or name

1 reference

1 January 1999

1 reference

2 December 2017

published in

Journal of neuro-AIDS

1 reference

2 December 2017

volume

2

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

29-35

1 reference

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ128V02N02_03

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ128V02N02_03

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ128V02N02_03

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ128V02N02_03

HIV-1 replication in the plasma and cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ128V02N02_03

21 January 2018

Identifiers

DOI

10.1300/J128V02N02_03

1 reference

2 December 2017

1 reference